Search for: "In re Barr" Results 521 - 540 of 1,024
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jan 2018, 12:57 pm by Andrew Delaney
 This is the second round, but we haven’t gotten to the first one yet either, so we’re starting from scratch here. [read post]
7 Jan 2018, 12:57 pm by Andrew Delaney
 This is the second round, but we haven’t gotten to the first one yet either, so we’re starting from scratch here. [read post]
18 Nov 2020, 10:50 am by Anna Salvatore, Tia Sewell
“We’re running into Thanksgiving now and that’s only going to make it worse. [read post]
7 Nov 2008, 3:42 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: CAFC affirms rejection of claim reciting broad genus of monoclonal antibodies for failure to satisfy written description requirement: In re Alonso… [read post]
4 May 2010, 11:40 am by FDABlog HPM
Barr Labs., Inc., (In re Tamoxifen Citrate Antitrust Litig.), 466 F.3d 187 (2d Cir. 2005), compelled it to do so: “Since Tamoxifen rejected antitrust challenges to reverse payments as a matter of law, we are bound to review the Cipro court’s rulings under the standard adopted in Tamoxifen. [read post]
3 Jun 2015, 9:55 am by Jennifer Driscoll and Helen C. Eckert
  However, in 2011 the court ruled that RE ‘516 was obtained by fraud on the patent office because Cephalon did not disclose that another company had invented the underlying drug formulation, thus invaliding the protection that would otherwise be accorded to RE ‘516. [read post]
9 Sep 2010, 12:20 pm by FDABlog HPM
Barr Labs., Inc., (In re Tamoxifen Citrate Antitrust Litig.), 466 F.3d 187 (2d Cir. 2005), compelled it to do so: “Since Tamoxifen rejected antitrust challenges to reverse payments as a matter of law, we are bound to review the Cipro court’s rulings under the standard adopted in Tamoxifen. [read post]
31 Jan 2014, 10:22 pm by Patti Waller
If you or a family member became ill with a Campylobacter infection, including Guillain-Barré Syndrome, or GBS, after consuming food and you’re interested in pursuing a legal claim, contact the Marler Clark Campylobacter attorneys for a free case evaluation. [read post]
12 Apr 2020, 9:05 pm by Dan Flynn
Attorney General William Barr has ordered the Bureau of Prisons to move some inmates to home confinement. [read post]
22 Aug 2012, 6:10 am by Staci Zaretsky
Is that what you’re alleging? [read post]
25 Feb 2011, 2:02 pm by Juliana
Why invest in the costly medicine if you’re only going to get slammed with a lawsuit as soon as it comes on the market? [read post]
11 Jun 2014, 2:51 pm by Tom Lamb
Claimants allege that they have ­suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and/or YAZ™ or from the use of Ocella™ and/or Gianvi™, generic versions of Yasmin™ and YAZ™, respectively, marketed by Barr Laboratories, Inc. in the United States. [read post]
14 Jul 2020, 5:53 am by Cassandra Maas
According to the Washington Post, his last words were “You’re killing an innocent man. [read post]